<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">nid</journal-id><journal-title-group><journal-title xml:lang="ru">Нефрология и диализ</journal-title><trans-title-group xml:lang="en"><trans-title>Nephrology and Dialysis</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1680-4422</issn><issn pub-type="epub">2618-9801</issn><publisher><publisher-name>Российское диализное общество</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.28996/2618-9801-2020-1-10-23</article-id><article-id custom-type="elpub" pub-id-type="custom">nid-192</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ПЕРЕДОВАЯ СТАТЬЯ - ВСЕМИРНЫЙ ДЕНЬ ПОЧКИ 2020</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>EDITORIAL - WORLD KIDNEY DAY 2020</subject></subj-group></article-categories><title-group><article-title>Здоровые почки всем и везде: от профилактики и выявления до равного доступа к медицинской помощи</article-title><trans-title-group xml:lang="en"><trans-title>Kidney health for everyone everywhere - from prevention to detection and equitable access to care</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Филипп</surname><given-names>Кам Тао</given-names></name><name name-style="western" xml:lang="en"><surname>Philip</surname><given-names>Kam-Tao Li</given-names></name></name-alternatives><email xlink:type="simple">philipli@cuhk.edu.hk</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Гильермо</surname><given-names>Гарсия-Гарсия</given-names></name><name name-style="western" xml:lang="en"><surname>Guillermo</surname><given-names>Garcia-Garcia</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Сиу-Фай</surname><given-names>Луи</given-names></name><name name-style="western" xml:lang="en"><surname>Siu-Fai</surname><given-names>Lui</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шэрон</surname><given-names>Андреоли</given-names></name><name name-style="western" xml:lang="en"><surname>Sharon</surname><given-names>Andreoli</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-4"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Уинстон</surname><given-names>Винг-Шинг Фунг</given-names></name><name name-style="western" xml:lang="en"><surname>Winston</surname><given-names>Wing-Shing Fung</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Анна</surname><given-names>Градски</given-names></name><name name-style="western" xml:lang="en"><surname>Anne</surname><given-names>Hradsky</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-5"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Латха</surname><given-names>Кумарасвами</given-names></name><name name-style="western" xml:lang="en"><surname>Latha</surname><given-names>Kumaraswami</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-6"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Василиос</surname><given-names>Лиакопулос</given-names></name><name name-style="western" xml:lang="en"><surname>Vassilios</surname><given-names>Liakopoulos</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-7"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Зиёда</surname><given-names>Рахимова</given-names></name><name name-style="western" xml:lang="en"><surname>Ziyoda</surname><given-names>Rakhimova</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-5"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Гамаль</surname><given-names>Саади</given-names></name><name name-style="western" xml:lang="en"><surname>Gamal</surname><given-names>Saadi</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-8"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Луиза</surname><given-names>Страни</given-names></name><name name-style="western" xml:lang="en"><surname>Luisa</surname><given-names>Strani</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-5"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ифеома</surname><given-names>Уласи</given-names></name><name name-style="western" xml:lang="en"><surname>Ifeoma</surname><given-names>Ulasi</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-9"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Камьяр</surname><given-names>Калантар-Заде</given-names></name><name name-style="western" xml:lang="en"><surname>Kamyar</surname><given-names>Kalantar-Zadeh</given-names></name></name-alternatives><email xlink:type="simple">kkz@uci.edu</email><xref ref-type="aff" rid="aff-10"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Отдел медицины и терапии, Исследовательский центр имени Кэрол и Ричарда Ю, Больница принца Уэльского, Китайский университет Гонконга, Гонконг</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Department of Medicine and Therapeutics, Carol &amp; Richard Yu PD Research Centre, Prince of Wales Hospital, Chinese University of Hong Kong, Hong Kong</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Отделение нефрологии, Гвадалахарский гражданский госпиталь имени Фрая Антонио Алькальде, Научный центр здоровья Университета Гвадалахары, Гвадалахара, штат Халиско, Мексика</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Nephrology Service, Hospital Civil de Guadalajara Fray Antonio Alcalde, University of Guadalajara Health Sciences Center, Guadalajara, Jal., Mexico</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>Отдел организации и управления здравоохранением, Школа общественного здравоохранения и первичной медико-санитарной помощи «Жокей-клуб», Китайский университет Гонконга, Гонконг</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Division of Health System, Policy and Management, Jockey Club School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-4"><aff xml:lang="ru"><institution>Больница имени Джейма Уиткомба Райли для детей, Медицинская школа Университета Индианы, Инианополис, США</institution><country>Россия</country></aff><aff xml:lang="en"><institution>James Whitcomb Riley Hospital for Children, Indiana University School Of Medicine, Indianapolis, USA</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-5"><aff xml:lang="ru"><institution>Головной офис инициативы «Всемирный день почки», улица Искусств 1-2, 6 этаж, B-1210, Брюссель, Бельгия</institution><country>Россия</country></aff><aff xml:lang="en"><institution>World Kidney Day Office, Avenue des Arts 1-2, 6th floor, B-1210, Brussels, Belgium</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-6"><aff xml:lang="ru"><institution>Фонд Танкер, Ченнаи, Индия</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Tanker Foundation, Chennai, India</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-7"><aff xml:lang="ru"><institution>Отдел нефрологии и артериальной гипертензии, 1-я кафедра терапии и внутренних болезней, госпиталь Aмериканской эллинской образовательной ассоциации, Университет имени Аристотеля в Салониках, Салоники, Греция</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Division of Nephrology and Hypertension, 1st Department of Internal Medicine, AHEPA Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-8"><aff xml:lang="ru"><institution>Отдел внутренних болезней, медицинский факультет, Каирский университет, Гиза, Египет</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Nephrology Unit, Department of Internal Medicine, Faculty of Medicine, Cairo University, Giza, Egypt</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-9"><aff xml:lang="ru"><institution>Отделение нефрологии, медицинский факультет, Медицинский колледж, Университет Нигерии, Итуку-Озалла, Энугу, Нигерия</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Renal Unit, Department of Medicine, College of Medicine, University of Nigeria, Ituku-Ozalla, Enugu, Nigeria</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-10"><aff xml:lang="ru"><institution>Отдел нефрологии, артериальной гипертензии и трансплантации почки, Медицинская школа г. Ирвайн, Калифорнийский университет, Ориндж, Калифорния, США</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Division of Nephrology and Hypertension and Kidney Transplantation, University of California Irvine School of Medicine, Orange, CA, USA</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2020</year></pub-date><pub-date pub-type="epub"><day>26</day><month>07</month><year>2024</year></pub-date><volume>22</volume><issue>1</issue><fpage>10</fpage><lpage>23</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Филипп К.Т., Гильермо Г., Сиу-Фай Л., Шэрон А., Уинстон В.Ф., Анна Г., Латха К., Василиос Л., Зиёда Р., Гамаль С., Луиза С., Ифеома У., Камьяр К., 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="ru">Филипп К.Т., Гильермо Г., Сиу-Фай Л., Шэрон А., Уинстон В.Ф., Анна Г., Латха К., Василиос Л., Зиёда Р., Гамаль С., Луиза С., Ифеома У., Камьяр К.</copyright-holder><copyright-holder xml:lang="en">Philip K.L., Guillermo G., Siu-Fai L., Sharon A., Winston W.F., Anne H., Latha K., Vassilios L., Ziyoda R., Gamal S., Luisa S., Ifeoma U., Kamyar K.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://journal.nephro.ru/jour/article/view/192">https://journal.nephro.ru/jour/article/view/192</self-uri><abstract><p>Перевод с английского Е.С. Камышовой под редакцией Е.В. Захаровой Перевод осуществлен по инициативе РДО, и одобрен Организационным комитетом Всемирного Дня Почки Глобальное бремя хронической болезни почек (ХБП) стремительно увеличивается: так, согласно прогнозам, к 2040 г. ХБП окажется на пятом месте среди наиболее частых причин сокращения продолжительности жизни во всем мире. Более того, ХБП является основной причиной катастрофических расходов на здравоохранение. В странах с высоким уровнем дохода расходы на диализ и трансплантацию составляют до 3% от ежегодного бюджета здравоохранения. В связи с этим особенно важно, что развитие и прогрессирование ХБП во многих случаях можно предотвратить. В 2020 году кампания «Всемирный День Почки» посвящена в первую очередь мероприятиям по первичной, вторичной и третичной профилактике ХБП. В данной статье представлены описание и анализ мер, которые могут быть внедрены в каждой стране с целью пропаганды и дальнейшего развития профилактики ХБП. Первичная профилактика заболеваний почек должна быть направлена на модификацию факторов риска и устранение структурных повреждений почек и мочевыводящих путей, а также ограничение воздействия факторов риска окружающей среды и нефротоксических веществ. У лиц, уже страдающих заболеваниями почек, вторичная профилактика (включая оптимизацию артериального давления и контроль гликемии) должна быть основной целью как обучения, так и клинических вмешательств. У пациентов с далеко зашедшими стадиями ХБП настоятельно рекомендуются превентивные меры, позволяющие предотвратить или отсрочить потребность в диализе или трансплантации почки, а именно - лечение уремии и сопутствующих состояний, таких как сердечно-сосудистые заболевания. Для реализации профилактического подхода необходимо принятие мер на государственном уровне. Несмотря на то, что в той или иной стране может существовать национальная политика и стратегия по профилактике неинфекционных заболеваний в целом, конкретные меры, направленные на повышение осведомленности и настороженности в отношении диагностики, ведения и лечения ХБП, часто отсутствуют. В связи с этим необходимо повышение информированности населения, медицинских работников и политиков о важной роли профилактических мероприятий.</p></abstract><trans-abstract xml:lang="en"><p>The global burden of chronic kidney disease (CKD) is rapidly increasing with a projection of becoming the 5th most common cause of years of life lost globally by 2040. Aggravatingly, CKD is a major cause of catastrophic health expenditure. The costs of dialysis and transplantation consume up to 3% of the annual healthcare budget in high-income countries. Crucially, however, the onset and progression of CKD is often preventable. In 2020, the World Kidney Day campaign highlights the importance of preventive interventions - be it primary, secondary or tertiary. This complementing article focuses on outlining and analyzing measures that can be implemented in every country to promote and advance CKD prevention. Primary prevention of kidney disease should focus on the modification of risk factors and addressing structural abnormalities of the kidney and urinary tracts, as well as exposure to environmental risk factors and nephrotoxins. In persons with pre-existing kidney disease, secondary prevention, including blood pressure optimization and glycemic control, should be the main goal of education and clinical interventions. In patients with advanced CKD, management of co-morbidities such as uremia and cardiovascular disease is a highly recommended preventative intervention to avoid or delay dialysis or kidney transplantation. Political efforts are needed to proliferate the preventive approach. While national policies and strategies for non-communicable diseases might be present in a country, specific policies directed toward education and awareness about CKD screening, management and treatment are often lacking. Hence, there is an urgent need to increase the awareness of the importance of preventive measures throughout populations, professionals and policy makers.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>заболевания почек</kwd><kwd>профилактика</kwd><kwd>выявление</kwd><kwd>осведомленность</kwd><kwd>Kidney diseases</kwd><kwd>prevention</kwd><kwd>detection</kwd><kwd>awareness</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">International Society of Nephrology. (2019). 2019 United Nations High Level Meeting on UHC: Moving Together to Build Kidney Health worldwide. Retrieved 20 July 2019, https://www.theisn.org/images/Advocacy_4_pager_2019_Final_WEB_pagebypage.pdf.</mixed-citation><mixed-citation xml:lang="en">International Society of Nephrology. (2019). 2019 United Nations High Level Meeting on UHC: Moving Together to Build Kidney Health worldwide. Retrieved 20 July 2019, https://www.theisn.org/images/Advocacy_4_pager_2019_Final_WEB_pagebypage.pdf.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Foreman KJ, Marquez N, Dolgert A, et al. Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016-40 for 195 countries and territories. Lancet 2018; 392(10159): 2052-90.</mixed-citation><mixed-citation xml:lang="en">Foreman KJ, Marquez N, Dolgert A, et al. Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016-40 for 195 countries and territories. Lancet 2018; 392(10159): 2052-90.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Essue BM, Laba TL, Knaul F, et al. Economic burden of chronic ill health and injuries for households in low- and middle-income countries. In: Jamison DT, Gelband H, Horton S, et al., eds. Disease Control Priorities Improving Health and Reducing Poverty,. 3 ed. Washington, DC: World Bank; 2018: 121-43.</mixed-citation><mixed-citation xml:lang="en">Essue BM, Laba TL, Knaul F, et al. Economic burden of chronic ill health and injuries for households in low- and middle-income countries. In: Jamison DT, Gelband H, Horton S, et al., eds. Disease Control Priorities Improving Health and Reducing Poverty,. 3 ed. Washington, DC: World Bank; 2018: 121-43.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Vanholder R, Annemans L, Brown E, et al. Reducing the costs of chronic kidney disease while delivering quality health care: a call to action. Nat Rev Nephrol 2017; 13(7): 393-409.</mixed-citation><mixed-citation xml:lang="en">Vanholder R, Annemans L, Brown E, et al. Reducing the costs of chronic kidney disease while delivering quality health care: a call to action. Nat Rev Nephrol 2017; 13(7): 393-409.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Luyckx VA, Tuttle KR, Garcia-Garcia G, et al. Reducing major risk factors for chronic kidney disease. Kidney Int Suppl (2011) 2017; 7(2): 71-87</mixed-citation><mixed-citation xml:lang="en">Luyckx VA, Tuttle KR, Garcia-Garcia G, et al. Reducing major risk factors for chronic kidney disease. Kidney Int Suppl (2011) 2017; 7(2): 71-87</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Luyckx VA, Tonelli M, Stanifer JW. The global burden of kidney disease and the sustainable development goals. Bull World Health Organ 2018; 96(6): 414-22D.</mixed-citation><mixed-citation xml:lang="en">Luyckx VA, Tonelli M, Stanifer JW. The global burden of kidney disease and the sustainable development goals. Bull World Health Organ 2018; 96(6): 414-22D.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Tonelli M, Muntner P, Lloyd A, et al. Risk of coronary events in people with chronic kidney disease compared with those with diabetes: a population-level cohort study. Lancet 2012; 380(9844): 807-14</mixed-citation><mixed-citation xml:lang="en">Tonelli M, Muntner P, Lloyd A, et al. Risk of coronary events in people with chronic kidney disease compared with those with diabetes: a population-level cohort study. Lancet 2012; 380(9844): 807-14</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Kalantar-Zadeh K and Fouque D. Nutritional Management of Chronic Kidney Disease. N Engl J Med. 2017; 377(18):1765-1776.</mixed-citation><mixed-citation xml:lang="en">Kalantar-Zadeh K and Fouque D. Nutritional Management of Chronic Kidney Disease. N Engl J Med. 2017; 377(18):1765-1776.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">United Nations General Assembly. Political declaration of the third high-level meeting of the General Assembly on the prevention and control of non-communicable diseases (2018) Retrieved from https://www.un.org/ga/search/view_doc.asp?symbol=A/73/L.2&amp;Lang=E</mixed-citation><mixed-citation xml:lang="en">United Nations General Assembly. Political declaration of the third high-level meeting of the General Assembly on the prevention and control of non-communicable diseases (2018) Retrieved from https://www.un.org/ga/search/view_doc.asp?symbol=A/73/L.2&amp;Lang=E</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Lopez AD, et al. (2014, October 22). Remembering the forgotten non-communicable diseases. BMC Medicines, 200.</mixed-citation><mixed-citation xml:lang="en">Lopez AD, et al. (2014, October 22). Remembering the forgotten non-communicable diseases. BMC Medicines, 200.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">(CDC) Center for Disease Control and Prevention. “Picture of America” (www.cdc.gov/pictureofamerica). At a Glance - Executive Summary. 2017;2019.</mixed-citation><mixed-citation xml:lang="en">(CDC) Center for Disease Control and Prevention. “Picture of America” (www.cdc.gov/pictureofamerica). At a Glance - Executive Summary. 2017;2019.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Levey AS, Schoolwerth AC, Burrows NR, Williams DE, Stith KR, McClellan W, Centers for Disease Control and Prevention Expert Panel. Comprehensive public health strategies for preventing the development, progression, and complications of CKD: report of an expert panel convened by the Centers for Disease Control and Prevention. Am J Kidney Dis. 2009;53(3):522-35.</mixed-citation><mixed-citation xml:lang="en">Levey AS, Schoolwerth AC, Burrows NR, Williams DE, Stith KR, McClellan W, Centers for Disease Control and Prevention Expert Panel. Comprehensive public health strategies for preventing the development, progression, and complications of CKD: report of an expert panel convened by the Centers for Disease Control and Prevention. Am J Kidney Dis. 2009;53(3):522-35.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Saran R, Robinson B, Abbott KC, Agodoa LYC, Bragg-Gresham J, Balkrishnan R, Bhave N, Dietrich X, Ding Z, Eggers PW, Gaipov A, Gillen D, Gipson D, Gu H, Guro P, Haggerty D, Han Y, He K, Herman W, Heung M, Hirth RA, Hsiung JT, Hutton D, Inoue A, Jacobsen SJ, Jin Y, Kalantar-Zadeh K, Kapke A, Kleine CE, Kovesdy CP, Krueter W, Kurtz V, Li Y, Liu S, Marroquin MV, McCullough K, Molnar MZ, Modi Z, Montez-Rath M, Moradi H, Morgenstern H, Mukhopadhyay P, Nallamothu B, Nguyen DV, Norris KC, O'Hare AM, Obi Y, Park C, Pearson J, Pisoni R, Potukuchi PK, Repeck K, Rhee CM, Schaubel DE, Schrager J, Selewski DT, Shamraj R, Shaw SF, Shi JM, Shieu M, Sim JJ, Soohoo M, Steffick D, Streja E, Sumida K, Kurella Tamura M, Tilea A, Turf M, Wang D, Weng W, Woodside KJ, Wyncott A, Xiang J, Xin X, Yin M, You AS, Zhang X, Zhou H and Shahinian V. US Renal Data System 2018 Annual Data Report: Epidemiology of Kidney Disease in the United States.Am J Kidney Dis. 2019;73(3S1):A7-A8.</mixed-citation><mixed-citation xml:lang="en">Saran R, Robinson B, Abbott KC, Agodoa LYC, Bragg-Gresham J, Balkrishnan R, Bhave N, Dietrich X, Ding Z, Eggers PW, Gaipov A, Gillen D, Gipson D, Gu H, Guro P, Haggerty D, Han Y, He K, Herman W, Heung M, Hirth RA, Hsiung JT, Hutton D, Inoue A, Jacobsen SJ, Jin Y, Kalantar-Zadeh K, Kapke A, Kleine CE, Kovesdy CP, Krueter W, Kurtz V, Li Y, Liu S, Marroquin MV, McCullough K, Molnar MZ, Modi Z, Montez-Rath M, Moradi H, Morgenstern H, Mukhopadhyay P, Nallamothu B, Nguyen DV, Norris KC, O'Hare AM, Obi Y, Park C, Pearson J, Pisoni R, Potukuchi PK, Repeck K, Rhee CM, Schaubel DE, Schrager J, Selewski DT, Shamraj R, Shaw SF, Shi JM, Shieu M, Sim JJ, Soohoo M, Steffick D, Streja E, Sumida K, Kurella Tamura M, Tilea A, Turf M, Wang D, Weng W, Woodside KJ, Wyncott A, Xiang J, Xin X, Yin M, You AS, Zhang X, Zhou H and Shahinian V. US Renal Data System 2018 Annual Data Report: Epidemiology of Kidney Disease in the United States.Am J Kidney Dis. 2019;73(3S1):A7-A8.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Kovesdy CP, Furth SL, Zoccali C, World Kidney Day Steering Committee. Obesity and Kidney Disease: Hidden Consequences of the Epidemic. J Ren Nutr. 2017;27(2):75-77.</mixed-citation><mixed-citation xml:lang="en">Kovesdy CP, Furth SL, Zoccali C, World Kidney Day Steering Committee. Obesity and Kidney Disease: Hidden Consequences of the Epidemic. J Ren Nutr. 2017;27(2):75-77.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Tantisattamo E, Dafoe DC, Reddy UG, Ichii H, Rhee CM, Streja E, Landman J and Kalantar-Zadeh K. Current Management of Acquired Solitary Kidney. Kidney International Reports. 2019;4(9):1205-1218</mixed-citation><mixed-citation xml:lang="en">Tantisattamo E, Dafoe DC, Reddy UG, Ichii H, Rhee CM, Streja E, Landman J and Kalantar-Zadeh K. Current Management of Acquired Solitary Kidney. Kidney International Reports. 2019;4(9):1205-1218</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Webster AC, Nagler EV, Morton RL and Masson P. Chronic Kidney Disease. Lancet. 2017;389(10075):1238-1252</mixed-citation><mixed-citation xml:lang="en">Webster AC, Nagler EV, Morton RL and Masson P. Chronic Kidney Disease. Lancet. 2017;389(10075):1238-1252</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Koppe L and Fouque D. The Role for Protein Restriction in Addition to Renin-Angiotensin-Aldosterone System Inhibitors in the Management of CKD. Am J Kidney Dis. 2019;73(2):248-257.</mixed-citation><mixed-citation xml:lang="en">Koppe L and Fouque D. The Role for Protein Restriction in Addition to Renin-Angiotensin-Aldosterone System Inhibitors in the Management of CKD. Am J Kidney Dis. 2019;73(2):248-257.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Rifkin DE, Coca SG and Kalantar-Zadeh K. Does AKI truly lead to CKD? J Am Soc Nephrol. 2012;23(6):979-84</mixed-citation><mixed-citation xml:lang="en">Rifkin DE, Coca SG and Kalantar-Zadeh K. Does AKI truly lead to CKD? J Am Soc Nephrol. 2012;23(6):979-84</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Torres VE et al, Tolvaptan in patients with autosomal dominant polycystic kidney disease. NEngl JMed 2012;367(25):2407-18</mixed-citation><mixed-citation xml:lang="en">Torres VE et al, Tolvaptan in patients with autosomal dominant polycystic kidney disease. NEngl JMed 2012;367(25):2407-18</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Verhave JC, Troyanov S, Mongeau F et al. Prevalence, awareness, and management of CKD and cardiovascular risk factors in publiclyfunded health care. Clin J AmSocNephrol 2014; 9: 713-9.</mixed-citation><mixed-citation xml:lang="en">Verhave JC, Troyanov S, Mongeau F et al. Prevalence, awareness, and management of CKD and cardiovascular risk factors in publiclyfunded health care. Clin J AmSocNephrol 2014; 9: 713-9.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Chow KM, Szeto CC, Kwan B, Leung CB, Li PK. Public lacksknowledge on chronic kidney disease: Telephone survey. Hong Kong Med J 2014; 20: 139-44.</mixed-citation><mixed-citation xml:lang="en">Chow KM, Szeto CC, Kwan B, Leung CB, Li PK. Public lacksknowledge on chronic kidney disease: Telephone survey. Hong Kong Med J 2014; 20: 139-44.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Ene-Iordache B, Perico N, Bikbov B et al. Chronic kidney diseaseand cardiovascular risk in six regions of the world (ISN-KDDC): Across-sectional study. Lancet Glob Health 2016; 4: e307-19.</mixed-citation><mixed-citation xml:lang="en">Ene-Iordache B, Perico N, Bikbov B et al. Chronic kidney diseaseand cardiovascular risk in six regions of the world (ISN-KDDC): Across-sectional study. Lancet Glob Health 2016; 4: e307-19.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Li PKT, Weening JJ, Dirks J, et al. A report with consensus statements of the International Society of Nephrology 2004 Consensus Workshop on Prevention of Progression of Renal Disease. Kidney Int Suppl 2005 Apr;(94):s2-7</mixed-citation><mixed-citation xml:lang="en">Li PKT, Weening JJ, Dirks J, et al. A report with consensus statements of the International Society of Nephrology 2004 Consensus Workshop on Prevention of Progression of Renal Disease. Kidney Int Suppl 2005 Apr;(94):s2-7</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Vassalotti JA, Stevens LA, Levey AS. Testing for chronic kidneydisease: A position statement from the National KidneyFoundation. Am. J. Kidney Dis. 2007; 50: 169-80.</mixed-citation><mixed-citation xml:lang="en">Vassalotti JA, Stevens LA, Levey AS. Testing for chronic kidneydisease: A position statement from the National KidneyFoundation. Am. J. Kidney Dis. 2007; 50: 169-80.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Levey AS, Atkins R, Coresh J et al. Chronic kidney disease as a global public health problem: Approaches and initiatives - aposition statement from Kidney Disease Improving Global Outcomes. Kidney Int. 2007; 72: 247-59.</mixed-citation><mixed-citation xml:lang="en">Levey AS, Atkins R, Coresh J et al. Chronic kidney disease as a global public health problem: Approaches and initiatives - aposition statement from Kidney Disease Improving Global Outcomes. Kidney Int. 2007; 72: 247-59.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Crowe E, Halpin D, Stevens P; Guideline Development Group.Early identification and management of chronic kidney disease: summary of NICE guidance. BMJ 2008;337:a1530.</mixed-citation><mixed-citation xml:lang="en">Crowe E, Halpin D, Stevens P; Guideline Development Group.Early identification and management of chronic kidney disease: summary of NICE guidance. BMJ 2008;337:a1530.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Li PKT, Chow KM, Matsuo S, et al. Asian Chronic Kidney Disease (CKD) Best Practice Recommendations - Positional Statements for Early Detection of CKD from Asian Forum for CKD Initiatives (AFCKDI). Nephrology (Carlton) 2011;16(7):633-641</mixed-citation><mixed-citation xml:lang="en">Li PKT, Chow KM, Matsuo S, et al. Asian Chronic Kidney Disease (CKD) Best Practice Recommendations - Positional Statements for Early Detection of CKD from Asian Forum for CKD Initiatives (AFCKDI). Nephrology (Carlton) 2011;16(7):633-641</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Fink HA, Ishani A, Taylor BC, Greer NL, MacDonald R, Rossini D, Sadiq S, Lankireddy S, Kane RL, Wilt TJ: Screening for, monitoring, and treatment of chronic kidney disease stages 1 to 3: A systematic review for the U.S. Preventive Services Task Force and for an American College of Physicians Clinical Practice Guideline. Ann Intern Med 2012;156: 570-581</mixed-citation><mixed-citation xml:lang="en">Fink HA, Ishani A, Taylor BC, Greer NL, MacDonald R, Rossini D, Sadiq S, Lankireddy S, Kane RL, Wilt TJ: Screening for, monitoring, and treatment of chronic kidney disease stages 1 to 3: A systematic review for the U.S. Preventive Services Task Force and for an American College of Physicians Clinical Practice Guideline. Ann Intern Med 2012;156: 570-581</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Li PKT, Ng JK, Cheng YL, Kwan TH, et al.Relatives In SilentKidney disease Screening study (RISKS): a Chinese cohort study. Nephrology (Carlton) 2017;22 Suppl 4:35-42</mixed-citation><mixed-citation xml:lang="en">Li PKT, Ng JK, Cheng YL, Kwan TH, et al.Relatives In SilentKidney disease Screening study (RISKS): a Chinese cohort study. Nephrology (Carlton) 2017;22 Suppl 4:35-42</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Samal L, Linder JA. The primary care perspective on routine urine dipstick screening to identify patients with albuminuria. Clin J Am Soc Nephrol 2013 Jan;8(1):131-5</mixed-citation><mixed-citation xml:lang="en">Samal L, Linder JA. The primary care perspective on routine urine dipstick screening to identify patients with albuminuria. Clin J Am Soc Nephrol 2013 Jan;8(1):131-5</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">George C, Mogueo A, Okpechi I, Echouffo-Tcheugui JB, Kengne AP. Chronic kidney disease in low-income to middle-income countries: the case for increased screening. BMJ Glob Health 2017;2(2):e000256</mixed-citation><mixed-citation xml:lang="en">George C, Mogueo A, Okpechi I, Echouffo-Tcheugui JB, Kengne AP. Chronic kidney disease in low-income to middle-income countries: the case for increased screening. BMJ Glob Health 2017;2(2):e000256</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Gonzalez-Quiroz M, Nitsch D, Hamilton S, O'Callaghan Gordo C, Saran R, Glaser J, Correa-Rotter R, Jakobsson K, Singh A, Gunawardena N, Levin A, Remuzzi G, Caplin B, Pearce N; DEGREE Study Steering Committee.Rationale and population-based prospective cohort protocol for the disadvantaged populations at risk of decline in eGFR (CO-DEGREE). BMJ Open 2019;9:e031169</mixed-citation><mixed-citation xml:lang="en">Gonzalez-Quiroz M, Nitsch D, Hamilton S, O'Callaghan Gordo C, Saran R, Glaser J, Correa-Rotter R, Jakobsson K, Singh A, Gunawardena N, Levin A, Remuzzi G, Caplin B, Pearce N; DEGREE Study Steering Committee.Rationale and population-based prospective cohort protocol for the disadvantaged populations at risk of decline in eGFR (CO-DEGREE). BMJ Open 2019;9:e031169</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Boulware LE, Jaar BG, Tarver-Carr ME, Brancati FL, Powe NR. Screening for proteinuria in US adults: A cost-effectiveness analysis. JAMA 2003; 290: 3101-14.</mixed-citation><mixed-citation xml:lang="en">Boulware LE, Jaar BG, Tarver-Carr ME, Brancati FL, Powe NR. Screening for proteinuria in US adults: A cost-effectiveness analysis. JAMA 2003; 290: 3101-14.</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Go DS, Kim SH, Park J, Ryu DR, Lee HJ, Jo MW. Cost-utility analysis of the National Health Screening Program for chronic kidney disease in Korea. Nephrology (Carlton) 2019;24(1):56-64.</mixed-citation><mixed-citation xml:lang="en">Go DS, Kim SH, Park J, Ryu DR, Lee HJ, Jo MW. Cost-utility analysis of the National Health Screening Program for chronic kidney disease in Korea. Nephrology (Carlton) 2019;24(1):56-64.</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Komenda P, Ferguson TW, Macdonald K et al. Cost-effectiveness ofprimary screening for CKD: A systematic review. Am J Kidney Dis2014; 63: 789-97.</mixed-citation><mixed-citation xml:lang="en">Komenda P, Ferguson TW, Macdonald K et al. Cost-effectiveness ofprimary screening for CKD: A systematic review. Am J Kidney Dis2014; 63: 789-97.</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Hwang SJ, Tsai JC, Chen HC. Epidemiology, impact and preventive care of chronic kidney disease in Taiwan. Nephrology (Carlton). 2010 Jun;15 Suppl 2:3-9.</mixed-citation><mixed-citation xml:lang="en">Hwang SJ, Tsai JC, Chen HC. Epidemiology, impact and preventive care of chronic kidney disease in Taiwan. Nephrology (Carlton). 2010 Jun;15 Suppl 2:3-9.</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Almaguer M, Herrera R, Alfonso J, MagransC, MañalichR, Martínez A. Primary health care strategies for the prevention of end-stage renal disease in Cuba. Kidney Int Suppl 2005; 97: S4-10.</mixed-citation><mixed-citation xml:lang="en">Almaguer M, Herrera R, Alfonso J, MagransC, MañalichR, Martínez A. Primary health care strategies for the prevention of end-stage renal disease in Cuba. Kidney Int Suppl 2005; 97: S4-10.</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Alamaguer-Lopez M, Herrera-Valdez R, Diaz J, Rodriguez O. Integration of chronic kidney disease prevention into noncommunicable disease programs in Cuba. In G. Garcia-Garcia, L. Y. Agodoa, &amp; K. C. Norris (Eds.), Chronic Kidney Disease in Disadvantaged Populations 2017 (pp. 357-365). London: Elsevier Inc.</mixed-citation><mixed-citation xml:lang="en">Alamaguer-Lopez M, Herrera-Valdez R, Diaz J, Rodriguez O. Integration of chronic kidney disease prevention into noncommunicable disease programs in Cuba. In G. Garcia-Garcia, L. Y. Agodoa, &amp; K. C. Norris (Eds.), Chronic Kidney Disease in Disadvantaged Populations 2017 (pp. 357-365). London: Elsevier Inc.</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">U.S. Department of Health and Human Services. Advancing American Kidney Health., 2019 accessed Sept 26, 2019 https://aspe.hhs.gov/pdf-report/advancing-american-kidney-health</mixed-citation><mixed-citation xml:lang="en">U.S. Department of Health and Human Services. Advancing American Kidney Health., 2019 accessed Sept 26, 2019 https://aspe.hhs.gov/pdf-report/advancing-american-kidney-health</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">U.S. Department of Health and Human Services. The Special Diabetes Program for Indians. Estimates of Medicare savings., 2019. Accessed Sept 26, 2019 https://aspe.hhs.gov/pdf-report/special-diabetes-program-indians-estimates-medicare-savings</mixed-citation><mixed-citation xml:lang="en">U.S. Department of Health and Human Services. The Special Diabetes Program for Indians. Estimates of Medicare savings., 2019. Accessed Sept 26, 2019 https://aspe.hhs.gov/pdf-report/special-diabetes-program-indians-estimates-medicare-savings</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Bello AK, Nwankwo E, El Nahas AM. Prevention of chronic kidney disease: a global challenge. Kidney Int Suppl 2005;98:S11-17</mixed-citation><mixed-citation xml:lang="en">Bello AK, Nwankwo E, El Nahas AM. Prevention of chronic kidney disease: a global challenge. Kidney Int Suppl 2005;98:S11-17</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">James MT, Hemmelgarn BR, Tonelli M. Early recognition and prevention of chronic kidney disease. Lancet 2010; 375(9722), 1296-1309</mixed-citation><mixed-citation xml:lang="en">James MT, Hemmelgarn BR, Tonelli M. Early recognition and prevention of chronic kidney disease. Lancet 2010; 375(9722), 1296-1309</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Cortés-Sanabria L, Cabrera-Pivaral CE, Cueto-Manzano AM, Rojas-Campos E, Barragán G, Hernández-Anaya M, Martínez-Ramírez HR. Improving care of patients with diabetes and CKD: a pilot study for a cluster-randomized trial. Am J Kidney Dis, 2008; 51(5), 777-788</mixed-citation><mixed-citation xml:lang="en">Cortés-Sanabria L, Cabrera-Pivaral CE, Cueto-Manzano AM, Rojas-Campos E, Barragán G, Hernández-Anaya M, Martínez-Ramírez HR. Improving care of patients with diabetes and CKD: a pilot study for a cluster-randomized trial. Am J Kidney Dis, 2008; 51(5), 777-788</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Martínez-Ramírez HR, Jalomo-MartínezB, Cortés-SanabriaL, Rojas-Campos E, Barragán G, Alfaro G, Cueto-Manzano AM. Renal function preservation in type 2 diabetes mellitus patients with early nephropathy: a comparative prospective cohort study between primary health care doctors and a nephrologist. Am J Kidney Dis 2006; 47(1), 78-87</mixed-citation><mixed-citation xml:lang="en">Martínez-Ramírez HR, Jalomo-MartínezB, Cortés-SanabriaL, Rojas-Campos E, Barragán G, Alfaro G, Cueto-Manzano AM. Renal function preservation in type 2 diabetes mellitus patients with early nephropathy: a comparative prospective cohort study between primary health care doctors and a nephrologist. Am J Kidney Dis 2006; 47(1), 78-87</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Cueto-Manzano AM, Martínez-Ramírez HR, Cortes-Sanabria L, Rojas-Campos E. CKD screening and prevention strategies in disadvantaged populations. The role of primary health care professionals. In G. Garcia-Garcia, L. Y. Agodoa, &amp; K. C. Norrris (Eds.), Chronic Kidney Disease in Disadvantaged Populations. 2017 (pp. 329-335). London: Elsevier, Inc.</mixed-citation><mixed-citation xml:lang="en">Cueto-Manzano AM, Martínez-Ramírez HR, Cortes-Sanabria L, Rojas-Campos E. CKD screening and prevention strategies in disadvantaged populations. The role of primary health care professionals. In G. Garcia-Garcia, L. Y. Agodoa, &amp; K. C. Norrris (Eds.), Chronic Kidney Disease in Disadvantaged Populations. 2017 (pp. 329-335). London: Elsevier, Inc.</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru">Tapia-Conyer R, Gallardo-Rincon H, Betancourt-Cravioto M. Chronic kidney disease in disadvantaged populations: Online educational programs for NCD prevention and treatment. In G. Garcia-Garcia, L. Y. Agodoa, &amp; K. C. Norris (Eds.), Chronic Kidney Disease in Disadvantaged Populations. 2017 (pp. 337-345). London: Elsevier, Inc.</mixed-citation><mixed-citation xml:lang="en">Tapia-Conyer R, Gallardo-Rincon H, Betancourt-Cravioto M. Chronic kidney disease in disadvantaged populations: Online educational programs for NCD prevention and treatment. In G. Garcia-Garcia, L. Y. Agodoa, &amp; K. C. Norris (Eds.), Chronic Kidney Disease in Disadvantaged Populations. 2017 (pp. 337-345). London: Elsevier, Inc.</mixed-citation></citation-alternatives></ref><ref id="cit47"><label>47</label><citation-alternatives><mixed-citation xml:lang="ru">Bello AK, Levin A, Manns BJ, Feehally J, Drueke T, Faruque L, Hemmelgarn BR, Kernahan C, Mann J, Klarenbach S, Remuzzi G, Tonelli M; Kidney Health for Life Initiative.Effective CKD care in European countries: challenges and opportunities for health policy. Am J Kidney Dis 2015; 65(1), 15-25</mixed-citation><mixed-citation xml:lang="en">Bello AK, Levin A, Manns BJ, Feehally J, Drueke T, Faruque L, Hemmelgarn BR, Kernahan C, Mann J, Klarenbach S, Remuzzi G, Tonelli M; Kidney Health for Life Initiative.Effective CKD care in European countries: challenges and opportunities for health policy. Am J Kidney Dis 2015; 65(1), 15-25</mixed-citation></citation-alternatives></ref><ref id="cit48"><label>48</label><citation-alternatives><mixed-citation xml:lang="ru">Sharif MU, Elsayed M E, Stack AG. The global nephrology workforce: emerging threats and potential solutions! Clin Kidney J 2016; 9(1), 11-22.</mixed-citation><mixed-citation xml:lang="en">Sharif MU, Elsayed M E, Stack AG. The global nephrology workforce: emerging threats and potential solutions! Clin Kidney J 2016; 9(1), 11-22.</mixed-citation></citation-alternatives></ref><ref id="cit49"><label>49</label><citation-alternatives><mixed-citation xml:lang="ru">Naicker S, Eastwood JB, Plange-Rhule J, Tutt RC. Shortage of healthcare workers in sub-Saharan Africa: a nephrological perspective. Clin Nephrol 2010; 74 Suppl 1, S129-133.</mixed-citation><mixed-citation xml:lang="en">Naicker S, Eastwood JB, Plange-Rhule J, Tutt RC. Shortage of healthcare workers in sub-Saharan Africa: a nephrological perspective. Clin Nephrol 2010; 74 Suppl 1, S129-133.</mixed-citation></citation-alternatives></ref><ref id="cit50"><label>50</label><citation-alternatives><mixed-citation xml:lang="ru">Cusumano AM, Rosa-Diez GJ, Gonzalez-Bedat MC. Latin American Dialysis and Transplant Registry: Experience and contributions to end-stage renal disease epidemiology. World J Nephrol 2016; 5(5), 389-397.</mixed-citation><mixed-citation xml:lang="en">Cusumano AM, Rosa-Diez GJ, Gonzalez-Bedat MC. Latin American Dialysis and Transplant Registry: Experience and contributions to end-stage renal disease epidemiology. World J Nephrol 2016; 5(5), 389-397.</mixed-citation></citation-alternatives></ref><ref id="cit51"><label>51</label><citation-alternatives><mixed-citation xml:lang="ru">Feehally J, Brusselmans A, Finkelstein FO, Harden P, Harris D, Manuzi G, Naicker S, Tonelli M, Cameron H. Improving global health: measuring the success of capacity building outreach programs: a view from the International Society of Nephrology. Kidney Int Suppl (2011). 2016; 6(2):42-51</mixed-citation><mixed-citation xml:lang="en">Feehally J, Brusselmans A, Finkelstein FO, Harden P, Harris D, Manuzi G, Naicker S, Tonelli M, Cameron H. Improving global health: measuring the success of capacity building outreach programs: a view from the International Society of Nephrology. Kidney Int Suppl (2011). 2016; 6(2):42-51</mixed-citation></citation-alternatives></ref><ref id="cit52"><label>52</label><citation-alternatives><mixed-citation xml:lang="ru">Harris DC, Dupuis S, Couser WG, Feehally J. Training nephrologists from developing countries: does it have a positive impact? Kidney Int Suppl (2011). 2012;2(3):275-278</mixed-citation><mixed-citation xml:lang="en">Harris DC, Dupuis S, Couser WG, Feehally J. Training nephrologists from developing countries: does it have a positive impact? Kidney Int Suppl (2011). 2012;2(3):275-278</mixed-citation></citation-alternatives></ref><ref id="cit53"><label>53</label><citation-alternatives><mixed-citation xml:lang="ru">Morbidity and mortality of renal dialysis: an NIH consensus conference statement. Consensus Development Conference Panel. Ann Intern Med 1994; 121(1), 62-70.</mixed-citation><mixed-citation xml:lang="en">Morbidity and mortality of renal dialysis: an NIH consensus conference statement. Consensus Development Conference Panel. Ann Intern Med 1994; 121(1), 62-70.</mixed-citation></citation-alternatives></ref><ref id="cit54"><label>54</label><citation-alternatives><mixed-citation xml:lang="ru">Garcia-Garcia G, Martinez-Castellanos Y, Renoirte-Lopez K, Barajas-Murguia A, de la Torre-Campos L, Becerra-Muñoz LE, Gonzalez-Alvarez JA, Tonelli M. Multidisciplinary care for poor patients with chronic kidney disease in Mexico. Kidney Int Suppl (2011). 2013;3(2):178-183</mixed-citation><mixed-citation xml:lang="en">Garcia-Garcia G, Martinez-Castellanos Y, Renoirte-Lopez K, Barajas-Murguia A, de la Torre-Campos L, Becerra-Muñoz LE, Gonzalez-Alvarez JA, Tonelli M. Multidisciplinary care for poor patients with chronic kidney disease in Mexico. Kidney Int Suppl (2011). 2013;3(2):178-183</mixed-citation></citation-alternatives></ref><ref id="cit55"><label>55</label><citation-alternatives><mixed-citation xml:lang="ru">Stanifer JW, Von Isenburg M, Chertow GM, Anand S. Chronic kidney disease care models in low- and middle-income countries: a systematic review. BMJ Glob Health, 2018; 3(2), e000728.</mixed-citation><mixed-citation xml:lang="en">Stanifer JW, Von Isenburg M, Chertow GM, Anand S. Chronic kidney disease care models in low- and middle-income countries: a systematic review. BMJ Glob Health, 2018; 3(2), e000728.</mixed-citation></citation-alternatives></ref><ref id="cit56"><label>56</label><citation-alternatives><mixed-citation xml:lang="ru">Narva AS, Norton JM, Boulware LE. Educating Patients about CKD: The Path to Self-Management and Patient-Centered Care. Clin J Am Soc Nephrol. 2016; 7;11(4):694-703</mixed-citation><mixed-citation xml:lang="en">Narva AS, Norton JM, Boulware LE. Educating Patients about CKD: The Path to Self-Management and Patient-Centered Care. Clin J Am Soc Nephrol. 2016; 7;11(4):694-703</mixed-citation></citation-alternatives></ref><ref id="cit57"><label>57</label><citation-alternatives><mixed-citation xml:lang="ru">Schatell D. Web-based kidney education: supporting patient self-management. Semin Dial 2013;26(2):154-8.</mixed-citation><mixed-citation xml:lang="en">Schatell D. Web-based kidney education: supporting patient self-management. Semin Dial 2013;26(2):154-8.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
